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Abstract
Background:  The  Moraxella catarrhalis Hag protein, an Oca autotransporter adhesin, has
previously been shown to be important for adherence of this respiratory tract pathogen to human
middle ear and A549 lung cells.
Results: The present study demonstrates that adherence of M. catarrhalis isogenic hag mutant
strains to the human epithelial cell lines Chang (conjunctival) and NCIH292 (lung) is reduced by
50–93%. Furthermore, expressing Hag in a heterologous Escherichia coli background substantially
increased the adherence of recombinant bacteria to NCIH292 cells and murine type IV collagen.
Hag did not, however, increase the attachment of E. coli to Chang cells. These results indicate that
Hag directly mediates adherence to NCIH292 lung cells and collagen, but is not sufficient to confer
binding to conjunctival monolayers. Several in-frame deletions were engineered within the hag gene
of M. catarrhalis strain O35E and the resulting proteins were tested for their ability to mediate
binding to NCIH292 monolayers, middle ear cells, and type IV collagen. These experiments
revealed that epithelial cell and collagen binding properties are separable, and that residues 385–
705 of this ~2,000 amino acid protein are important for adherence to middle ear and NCIH292
cells. The region of O35E-Hag encompassing aa 706 to 1194 was also found to be required for
adherence to collagen. In contrast, β-roll repeats present in Hag, which are structural features
conserved in several Oca adhesins and responsible for the adhesive properties of Yersinia
enterocolitica YadA, are not important for Hag-mediated adherence.
Conclusion: Hag is a major adherence factor for human cells derived from various anatomical
sites relevant to pathogenesis by M. catarrhalis and its structure-function relationships differ from
those of other, closely-related autotransporter proteins.
Background
Autotransporter proteins form the largest known family of
virulence factors expressed by Gram-negative bacteria,
and play central roles in processes such as cell-to-cell
aggregation, biofilm formation, serum resistance, and
adherence to host epithelial cells [1]. The members of this
family share structural features that include a surface-
exposed passenger domain specifying the biological activ-
ity of the protein and a C-terminal transporter module
comprised of several β-strands that anchors the autotrans-
porter in the outer membrane (OM). Based on the length
and structure of this transporter module, autotransporters
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can be classified as conventional (long module containing
12 β-strands) or trimeric (short module containing 4 β-
strands) [2]. One of the better characterized trimeric
autotransporter molecules is the Yersinia enterocolitica
adhesin YadA; YadA and structurally related autotrans-
porters are also often referred to as Oca (Oligomeric
coiled-coil adhesin) proteins [3]. Because of their struc-
ture and role in pathogenesis, autotransporters represent
promising targets for anti-infective approaches. Large por-
tions of these proteins (the passenger domains) are
located on the bacterial surface and are therefore amena-
ble to recognition by the immune system. In addition,
autotransporters play key roles in virulence and targeting
them may interfere with development of disease.
Moraxella catarrhalis is a Gram-negative bacterium that
causes a wide range of infections, including ~20% of all
cases of bacterial otitis media in children [4], up to 10%
of lung infections in elderly patients with Chronic
Obstructive Pulmonary Disease (COPD) [5], sinusitis [6],
and conjunctivitis [7]. This organism is a significant
health concern, and complicating this problem is the fact
that most M. catarrhalis clinical isolates display resistance
to antibiotics including β-lactams [8-10]. The develop-
ment of a vaccine for M. catarrhalis thus has increasing
importance for the health status of both the elderly and
the very young. This bacterium expresses several
autotransporter proteins that have been well-studied
including the trimeric/Oca adhesins UspA1 [3,11-18],
UspA2H [11], and Hag/MID [13,15,19-26], the trimeric/
Oca serum resistant factor UspA2 [3,11,16,17,27,28], and
the conventional autotransporter adhesin/phospholipase
B McaP [29,30].
Expression of Hag, or its ortholog MID (Moraxella IgD-
binding protein), is important for attachment to erythro-
cytes as well as A549 (lung pneumocytes) and HMEE
(human middle ear epithelial) cells [22-24,26], and Hag
directly mediates adherence to HMEE cells [26]. In addi-
tion, Hag binds immunoglobulin D and forms oligomers
[13,19,21,22,24]. The gene coding for this protein is
found in almost all M. catarrhalis isolates studied to date
[24,26], and specifies a relatively well-conserved molecule
of ~2,000 residues in length. Expression of Hag is subject
to translational phase variation, via slipped strand mis-
pairing in a homopolymeric guanine tract located near the
beginning of the ORF [13,24,26]. Hag has also been
found to contain a series of degenerate amino acid (aa)
repeats similar to those present in the N-terminus of the
prototypical Oca adhesin YadA and which specify the
adhesive properties of this Y. enterocolitica protein
[26,31,32].
In this study, we sought to determine what role Hag plays
in  M. catarrhalis adherence to lung mucoepidermoid
(NCIH292) and conjunctival (Chang) cells by measuring
the binding of Hag isogenic mutants and of recombinant
E. coli expressing wild-type (WT) hag  genes to these
human cells. We also sought to identify the region(s) of
Hag important for adherence using a panel of in-frame
hag deletion constructs.
Results
Hag expression is important for the adherence of M. 
catarrhalis to NCIH292 and Chang cells in vitro
Previous work demonstrated that Hag plays an important
role in the attachment of M. catarrhalis to HMEE cells and
A549 human type II pneumocytes [23,26]. To further
explore the role of this protein in adherence to human
epithelial cells that are relevant to pathogenesis by M.
catarrhalis, a panel of previously-described WT isolates
and cognate hag mutant strains [26] were tested for their
ability to bind to NCIH292 lung mucoepidermoid and
Chang conjunctival cells. Of note, these mutants were pre-
viously shown to have reduced adherence to A549 and
HMEE cells [26].
Strain TTA37 attached poorly to NCIH292 monolayers
and the adherence of its hag mutant, TTA37.Hag, was not
significantly lower (data not shown). Hag-deficient
strains derived from isolates V1171, O35E, McGHS1 and
O12E did not attach as efficiently to NCIH292 cells as
their respective WT progenitors (Fig. 1A). The binding of
V1171.Hag, O35E.TN2 and McGHS1.Hag to these mon-
olayers was about a third that of their parent strains
V1171, O35E, and McGHS1, respectively. Though the
two-fold difference between strains O12E and O12E.Hag
was not statistically significant, the preponderance of our
data suggests that Hag expression is important for the
adherence of M. catarrhalis to NCIH292 lung cells.
Similar results were obtained when the WT and isogenic
mutant strains were tested for their ability to bind to
Chang conjunctival cells. The hag  mutants of strains
V1171, O12E and McGHS1 all adhered significantly less
than their WT progenitors (Fig. 1B). Strain TTA37 attached
well to Chang cells (unlike NCIH292 cells) and the adher-
ence of its Hag deficient mutant TTA37.Hag was reduced
by 93%. Strain O35E.TN2 did not show Hag-dependent
binding to Chang cells, though strain O35E did not attach
as well to these monolayers as the other WT M. catarrhalis
isolates tested. Taken together, these results indicate that
Hag expression is important for the binding of M. catarrh-
alis to conjunctival cells. Of note, all strains tested in this
study were previously shown to express WT levels of the
adhesins UspA2H (in the case of strain TTA37), UspA1,
McaP, and OMPCD [26], yet we found that Hag deletions
still substantially reduce adherence.BMC Microbiology 2007, 7:65 http://www.biomedcentral.com/1471-2180/7/65
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Hag directly confers binding to NCIH292 cells and murine 
type IV collagen
It is possible that absence of Hag in the OM of M. catarrh-
alis mutants affected the proper display of other adhesins,
which themselves mediate adherence to NCIH292 and
Chang monolayers. To determine whether Hag directly
mediates binding to these epithelial cells, recombinant E.
coli strains previously shown to express the hag gene prod-
uct of M. catarrhalis strain O12E, O35E or V1171 [26]
were tested in quantitative attachment assays. Of note,
these clones were previously shown to have gained the
ability to attach to HMEE cells [26]. As shown in Fig. 2A,
O12E-, O35E- and V1171-Hag conferred on E.coli  the
ability to bind to NCIH292 cells at levels that were ~5-,
~10- and ~15-fold greater than E. coli carrying the control
plasmid pCC1.3, respectively. In contrast, E. coli express-
ing these three Hag proteins did not show significant
increases in binding to Chang monolayers (Fig. 2B). These
results demonstrate that Hag directly mediates adherence
to NCIH292 cells, but its expression is not sufficient to
increase the binding of recombinant E. coli to Chang
monolayers.
Based on sequence and structural similarities, Hag
belongs to the Oca family of autotransporter adhesins
[26]. Y. enterocolitica YadA is the prototypical member of
this family and has been shown to directly mediate adher-
ence to different types of collagen [31-33], including type
IV [33-35]. E. coli cells expressing the Hag protein of M.
catarrhalis  strain O35E, O12E or V1171 were therefore
tested for their ability to bind to murine type IV collagen.
As shown in Fig. 2C, E. coli expressing O12E- and V1171-
Hag were ~35 times more adherent to collagen than the
negative control while recombinant bacteria expressing
O35E-Hag exhibited a ~80-fold increase in binding. These
data indicate that Hag proteins from different M. catarrh-
alis isolates directly mediate attachment to murine type IV
collagen when expressed in the E. coli background. How-
ever, our panel of M. catarrhalis WT and isogenic mutant
strains all bound poorly to collagen-coated wells (data
not shown).
Construction and surface-expression of mutated Hag 
proteins
To define the region(s) of Hag important for adherence to
epithelial cells and collagen, several in-frame deletions
were engineered in the hag ORF of strain O35E (specified
by the plasmid pELO35.Hag). Fig. 3 illustrates the various
deletion constructs that were made. These mutated Hag
proteins were tested for their ability to mediate the bind-
ing of recombinant E. coli to NCIH292 cells, HMEE cells
and murine collagen (see below). Sarkosyl-insoluble OM
proteins were also prepared from recombinant E. coli
expressing these constructs, and tested by immunoblot-
Adherence of M. catarrhalisstrains to NCIH292 (Panel A) and Chang (Panel B) cells Figure 1
Adherence of M. catarrhalisstrains to NCIH292 (Panel A) and Chang (Panel B) cells. Black bars correspond to WT 
isolates and hag isogenic mutant strains are represented by open bars. The results are expressed as the mean (± standard 
error) percentage of inoculated bacteria binding to monolayers. The number above each bar represents mean percentage; 
standard error is shown in parentheses. Asterisks indicate that the difference in adherence between a WT strain and its 
respective hag mutant is statistically significant.
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ting with Hag-reactive antibodies. As shown in Fig. 4, all
mutated Hag proteins were associated with the OM. The
polyclonal antibodies used in these westerns are against
the last 607 residues of O35E-Hag (i.e. His.Hag.CT, see
Methods) and encompass the transporter domain (Fig. 3).
This portion of Oca adhesins has been shown to be
important for oligomerization properties, which likely
accounts for the multiple bands reacting with anti-Hag
antibodies in Fig. 4.
To verify that these OM-located Hag proteins were
exposed on the bacterial surface, intact recombinant E. coli
cells were treated with proteinase K and analyzed by West-
ern blot using antibodies against Hag. As controls, protei-
nase K-treated bacteria were also probed with a
monoclonal antibody against the inner membrane-
anchored protein TonB [36] to demonstrate that a mini-
mal amount of the enzyme transversed across the OM and
into the periplasm of E. coli. Fig. 5 shows the results of a
representative experiment in which E. coli carrying the
plasmids pELO35.Hag, pBBHS2.24 and pBBHS3.20 were
incubated for 15 min on ice in the absence (lanes 1, 3 and
5) or presence (lanes 2, 4 and 6) of proteinase K. As shown
in Fig. 5A, incubation with the enzyme decreases the reac-
tivity of the Hag-specific monoclonal antibody 5D2 to the
cell lysates. By contrast, little to no degradation of TonB
was observed under these conditions (Fig. 5B). Longer
incubation with proteinase K resulted in the near-com-
plete digestion of Hag but also caused partial degradation
of TonB (data not shown). The data are therefore consist-
ent with the Hag proteins being exposed on the surface of
recombinant bacteria (personal communication from Dr.
Ray Larsen, Bowling Green State University); similar
results were obtained when E. coli expressing the other
mutated Hag proteins were treated with this enzyme (data
not shown).
Adhesive properties of recombinant Hag proteins 
containing in-frame deletions
As previously reported [26], one striking similarity
between the Y. enterocolitica adhesin YadA and O35E-Hag
is the presence of degenerate aa sequence repeats in their
N-termini, which in YadA form coiled parallel structures
described as a β-roll [31]. O35E-Hag contains 10 such N-
terminal repeats between residues 85–274 (see Fig. 3, top)
having the consensus sequence GxxSIAIGxx(A/S)xAx. For
comparison, the YadA β-roll repeats are xxxSVAIGxxSxAx
[26]. In this Y. enterocolitica adhesin, the repeated motifs
are followed by a "neck" region (HIM domain, Pfam
accession # PF05662), which is also present in O35E-Hag
after the β-roll repeats (aa 312–336 in Fig. 3). Of signifi-
cance, the β-roll specifies the adhesive properties of YadA,
and an intact neck region appears to be essential for the
proper display/stability of the β-roll since mutations in
either area abolishes YadA-dependent binding to human
cells and collagen [31-35]. Based on these observations,
we hypothesized that the β-roll and neck region located in
the N-terminus of O35E-Hag are responsible for epithelial
cell and/or collagen binding functions. To test this
hypothesis, the region of Hag encompassing only the β-
roll repeats (aa 71–283, construct 2.24 in Fig. 3) or the β-
roll structure and its associated neck (aa 71–384, con-
Adherence of recombinant E. coli bacteria expressing WT  Hag proteins Figure 2
Adherence of recombinant E. coli bacteria expressing 
WT Hag proteins. Panels A and B: Adherence is expressed 
as the mean percentage (± standard error) of inoculated bac-
teria binding to monolayers. Panel C: Adherence is 
expressed as the normalized mean number of bacteria per 
microscopic fields (± standard error) binding to collagen type 
IV coated wells. The number above each bar represents the 
mean; standard error is shown in parentheses. Asterisks indi-
cate that the difference in binding between E. coli expressing 
O35E-Hag (i.e. pELO35.Hag), O12E-Hag (i.e. pBBO12.Hag) 
or V1171-Hag (i.e. pSV1171.Hag) and the negative control is 
statistically significant.
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struct 3.20) were deleted. As shown in columns H and C
of Fig. 3, these mutations did not affect binding to HMEE
cells or collagen, respectively. In addition, E. coli cells
expressing these two deletion constructs attached to
NCIH292 monolayers well above background levels (Fig.
3, column N). These results oppose the hypothesis that
the N-terminal β-roll and associated neck region of O35E-
Hag specify adhesive properties.
Unlike YadA, which contains only one β-roll/neck combi-
nation, O35E-Hag contains a second neck region in its C-
terminus (aa 1842–1865 in Fig. 3) preceded by a β-roll
structure containing 8 "GxxSIAIGxx(A/S)xAx" repeats
(residues 1680–1798 in Fig. 3). This second β-roll/neck
combination of O35E-Hag is located prior to a predicted
membrane anchoring module and is presumably located
on the bacterial surface as part of Hag's autotransporter
Selected structural features of O35E-Hag, schematic representation of in-frame deletions introduced in the protein, and adher- ence of recombinant E. coli bacteria expressing mutated Hag Figure 3
Selected structural features of O35E-Hag, schematic representation of in-frame deletions introduced in the 
protein, and adherence of recombinant E. coli bacteria expressing mutated Hag. Selected structural features are 
shown above in relation to their physical location within the O35E-Hag protein. Deletions within the protein are represented 
by gaps. Construct names are shown to the left. The columns to the right of each construct indicate the binding of E. coli 
expressing the mutated protein to NCIH292 cells (N), HMEE (H) or collagen (C). Adherence to NCIH292 and HMEE cells is 
expressed as the mean percentage (standard error shown in parentheses) of inoculated bacteria binding to monolayers. Adher-
ence to collagen is expressed as the normalized mean number of bacteria per microscopic fields (standard error shown in 
parentheses) binding to collagen type IV coated wells; we estimated that 20 to 35 bacteria per microscopic field corresponds 
to 5–15% of input bacteria. Asterisks indicate that the difference in binding between E. coli expressing Hag proteins and the 
negative control is statistically significant. The negative control corresponds to E. coli carrying the plasmid control pCC1.3 and 
WT corresponds to recombinant bacteria harboring plasmid pELO35.Hag. The rectangles at the bottom indicate regions 
important for adherence to epithelial cells and collagen.
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passenger domain. To determine whether this C-terminal
β-roll structure specifies adhesive properties, residues
1546–1707 (encompassing 2 "GxxSIAIGxx(A/S)xAx"
motifs) were removed in construct 8.18, which also con-
tains the deletion of the N-terminal β-roll/neck area (Fig.
3). Expression of this doubly-deleted Hag protein still
conferred on E. coli cells the ability to bind to HMEE cells,
collagen and lung cells at or near WT levels (columns N,
H and C of Fig. 3). By contrast, recombinant bacteria
expressing the mutated adhesin construct 6.22, which
retains both β-roll/neck combinations but is missing resi-
dues 436–1538 (Fig. 3), no longer adhere to either epithe-
lial cells or collagen (columns N, H and C of Fig. 3). These
results therefore support rejection of the hypothesis that
the β-roll structures of O35E-Hag specify adhesive proper-
ties as they do in YadA. Our data also suggest that residues
385–1545 encompass the collagen and epithelial cell
binding domain(s) of this M. catarrhalis adhesin.
The M. catarrhalis strain Bc5 protein MID, a Hag ortholog,
binds human immunoglobulin D on the bacterial surface,
and MID residues 962–1200 are responsible for this bind-
ing [19,21,24]. Sequence analysis revealed that the region
of O35E-Hag encompassing aa 1113–1353 is 83% identi-
cal to the Bc5-MID IgD binding domain (not shown). Fur-
thermore, Hag mediates the binding of IgD by M.
catarrhalis strain O35E [13]. Thus, the possibility that the
IgD-binding domain of O35E-Hag is responsible for
adherence to human epithelial cells and collagen was
tested by removing aa 919–1538 (dotted rectangle labeled
"IgD binding" at the top of Fig. 3) from the already
mutated Hag protein 2.24, yielding the construct 5.12 (see
Fig. 3). As shown in Fig. 3, deleting the predicted IgD
binding region of O35E-Hag does not adversely affect
attachment to epithelial cells (columns N and H) but
completely abolishes binding to collagen (column C).
Adherence to human cells is therefore specified by a
region of O35E-Hag distinct from that important for
binding collagen, making these adhesive properties sepa-
rable.
The adhesive properties of constructs 8.18 and 5.12 sug-
gest that residues 385–918 contain the portion of O35E-
Hag mediating adherence to NCIH292 cells and HMEE
cells. Interestingly, previous sequence analysis by our lab-
oratory indicated that aa 715–863 of O35E-Hag are 73%
identical to residues 764–913 of M. catarrhalis Bc5 MID
[23]. This is noteworthy because others showed that a
purified and radioactively-labeled recombinant protein
encompassing this particular portion of Bc5 MID directly
binds to A549 cells and erythrocytes [22]. To determine
what role, if any, these aa have in adherence to NCIH292
cells, HMEE cells and collagen, most of the potential
A549/erythrocyte binding site of O35E-Hag (rectangle
labeled "A549"at the top of Fig. 3) was removed from the
already mutated Hag protein 8.18, yielding construct 10.9
(see Fig. 3). As shown in columns N and H of Fig. 3, E. coli
Western blot analysis of recombinant E. coli cells treated  with proteinase K Figure 5
Western blot analysis of recombinant E. coli cells 
treated with proteinase K. E. coli carrying the plasmids 
pELO35.Hag (lanes 1 and 2), pBBHS2.24 (lanes 3 and 4) and 
pBBHS3.20 (lanes 5 and 6) were incubated for 15 min on ice 
in the presence (lanes 2, 4 and 6) or absence (lanes 1, 3 and 
5) of proteinase K. These cells were lysed, resolved by SDS-
PAGE, transferred to PVDF membranes and probed with the 
anti-Hag antibody 5D2 (panel A) or anti-TonB antibody 4F1 
(panel B). Molecular weight markers are shown to the left in 
kDa.
- ++ - + - proteinase K
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Hag-reactive antibody
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B.
Western blot analysis of Sarkosyl-insoluble OM proteins  extracted from E. coli expressing Hag proteins Figure 4
Western blot analysis of Sarkosyl-insoluble OM pro-
teins extracted from E. coli expressing Hag proteins. 
OM preparations were obtained from E. coli carrying the 
plasmids pCC1.3 (lane 1), pELO35.Hag (lane 2), pBBHS2.24 
(lane 3), pBBHS3.20 (lane 4), pBBHS8.18 (lane 5), pBBHS6.22 
(lane 6), pBBHS5.12 (lane 7), pBBHS10.9 (lane 8) and 
pBBHS10.32 (lane 9). These preparations were resolved by 
SDS-PAGE, transferred to PVDF membranes and probed 
with antibodies against the purified recombinant protein 
His.Hag.CT. The figure is a composite of several western 
blot experiments in which OM preparations of the negative 
control (i.e. pCC1.3) and the positive control (i.e. 
pELO35.Hag) were included. Molecular weight markers are 
shown to the left in kDa. The numbers at the bottom of the 
western panel represent the predicted molecular weight of 
each Hag protein.
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expressing this construct attached to both NCIH292 lung
cells and HMEE cells at the same level as recombinant bac-
teria expressing the full length adhesin. However, these
recombinant bacteria, like those expressing 5.12, no
longer bound to collagen (column C of Fig. 3). Thus, the
results are consistent with residues 385–745 encompass-
ing a portion of O35E-Hag that is crucial for adherence to
NCIH292 monolayers and HMEE cells. This hypothesis is
also supported by the results of quantitative attachment
assays with construct 10.32, which was obtained by delet-
ing aa 385–705 from the adherence positive Hag con-
struct 8.18 (see Fig. 3); recombinant E. coli expressing
construct 10.32 no longer adhere to either NCIH292 or
HMEE cells (Fig. 3). The inability of constructs 5.12, 10.9
and 10.32 to mediate the binding of recombinant bacteria
to collagen suggests that a region of O35E-Hag starting
upstream of aa 706 and extending to at least residue 1194
is important for adherence to this extracellular matrix pro-
tein (Fig. 3).
Discussion
Previous reports established that Hag and its ortholog
MID play important roles in adherence of M. catarrhalis to
middle ear epithelial cells and A549 pneumocytes
[22,23,26]. Disruption of hag/mid in several M. catarrhalis
strains substantially decreased adherence to both cell
types, while expression of hag in a heterologous E. coli
background increased attachment to middle ear cells at
least 17-fold. The results of the present study extend these
findings and demonstrate that Hag expression is also
important for adherence to conjunctival (Chang) and
lung mucoepidermoid (NCIH292) epithelial cells (Fig.
1). These cell lines are relevant to pathogenesis by M.
catarrhalis as this organism is a causative agent of conjunc-
tivitis, otitis media and lung infections. Furthermore, our
data reveal that Hag directly mediates binding to
NCIH292 monolayers (Fig. 2A). Thus, Hag is a key adher-
ence factor for epithelial cells relevant to pathogenesis by
the bacterium, making the protein an attractive target for
anti-infective approaches.
Hag/MID exhibit several properties of a good vaccine can-
didate. Most M. catarrhalis isolates tested to date contain a
hag/mid  gene and express its product [13,15,22,24,26].
The protein also contains surface-exposed epitopes
[13,22,24], making it readily available for recognition by
the immune system, and immunization with a peptide
encompassing MID residues 713–964 increases clearance
Table 1: Strains and plasmids
Strain or plasmid Description Source or reference
M. catarrhalis
[26]
O35E Wild-type isolate [26]
O35E.TN2 Isogenic hag mutant strain of O35E [26]
O12E Wild-type isolate [26]
O12E.Hag Isogenic hag mutant strain of O12E [26]
TTA37 Wild-type isolate [26]
TTA37.Hag Isogenic hag mutant strain of TTA37 [26]
V1171 Wild-type isolate [26]
V1171.Hag Isogenic hag mutant strain of V1171 [26]
McGHS1 Wild-type isolate [26]
McGHS1.Hag Isogenic hag mutant strain of McGHS1 [26]
E. coli
EPI300 Cloning strain Epicentre
TUNER Expression strain Novagen
Plasmids
pETcoco-1 Protein expression vector, Cmr Novagen
pBBCT.77 pETcoco-1 expressing O35E-Hag aa 1358–1964 joined to six N-terminal histidine residues, Cmr This study
pCC1.3 Adherence negative plasmid control [48]
pCC1 Cloning vector, Cmr Epicentre
pELO35.Hag pCC1 expressing the entire O35E hag gene product, Cmr [26]
pBBO12.Hag pCC1 expressing the entire O12E hag gene product, Cmr [26]
pSV1171.Hag pCC1 expressing the entire V1171 hag gene product, Cmr [26]
pBBHS2.24 Deletion derivative of pELO35.Hag, missing aa 71–283 This study
pBBHS3.20 Deletion derivative of pELO35.Hag, missing aa 71–384 This study
pBBHS8.18 Deletion derivative of pELO35.Hag, missing aa 71–384 and 1546–1707 This study
pBBHS6.22 Deletion derivative of pELO35.Hag, missing aa 436–1538 This study
pBBHS5.12 Deletion derivative of pELO35.Hag, missing aa 71–283 and 919–1538 This study
pBBHS10.9 Deletion derivative of pELO35.Hag, missing aa 71–384, 746–1193 and 1546–1707 This study
pBBHS10.32 Deletion derivative of pELO35.Hag, missing aa 71–705 and 1546–1707 This studyBMC Microbiology 2007, 7:65 http://www.biomedcentral.com/1471-2180/7/65
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of M. catarrhalis from the lungs of infected mice [25]. Our
data demonstrating that Hag plays a central role in M.
catarrhalis  adherence, a crucial step in pathogenesis by
most infectious agents [37-39], strengthen the hypothesis
that this OM protein has vaccinogenic potential. We
believe that targeting functionally relevant regions of Hag
in a vaccine will interfere with colonization of susceptible
individuals by M. catarrhalis. Bacterial adhesins have
already proven to be efficacious vaccine antigens. For
example, immunization with the cell-binding domain of
the H. influenzae adhesin Hap elicits production of anti-
bodies that reduce attachment to human epithelial cells
and protect mice in a nasopharyngeal colonization model
[40]. Similarly, immunization with the adhesin FimH of
uropathogenic E. coli is protective in animal models of
infection [41,42]. Furthermore, all vaccines licensed for
use in the US against whooping cough contain the Borde-
tella pertussis filamentous hemagglutinin adhesin FHA
[43].
Also consistent with the vaccinogenic potential of Hag is
the demonstration that saliva collected from healthy
adults [44] and children colonized with M. catarrhalis [45]
contain antibodies against Hag. COPD patients recover-
ing from pulmonary exacerbations caused by this organ-
ism were also shown to have increased serum levels of
anti-Hag IgG [17,46]. In addition, Hag is a major target of
new IgA antibodies purified from the sputum of COPD
patients with M. catarrhalis infections who have success-
fully cleared the organism [16]. In fact, Hag is the only
OM protein out of several tested (i.e. UspA1, UspA2,
CopB, TbpB) which elicited an IgA response in all patients
[16]. This protective immune response, however, appears
to be strain specific as COPD patients get reinfected with
different M. catarrhalis isolates [5]. Hag is a large protein
(1964–2335 aa) that exhibits interstrain variability (57–
89% identity) [24,26]. These observations emphasize the
need to identify the region(s) of Hag specifying the best
vaccinogenic properties for protection against the major-
ity of M. catarrhalis isolates. To achieve this, we sought to
identify the region(s) of Hag specifying adhesive proper-
ties by deleting predicted structural domains of the pro-
tein. This approach has been successfully used to identify
the cell-binding domains of other autotransporter adhes-
ins such as Y. enterocolitica YadA [32] and H. influenzae
Hap [47].
The involvement of Hag in adherence by M. catarrhalis is
complex. While the protein itself is sufficient to directly
mediate binding to middle ear [26] and NCIH292 lung
cells (Fig. 2A), the exact role of Hag in attachment to A549
and Chang cells is not clear. As shown in Fig. 1B, lack of
Hag expression in strains TTA37.Hag, V1171.Hag,
McGHS1.Hag and O12E.Hag reduces binding to Chang
monolayers 70–90%, but Hag expression does not confer
on E. coli the ability to attach to these conjunctival cells
(Fig. 2B). These results are similar to those previously
reported by our laboratory, where it was discovered that
Hag expression is important for WT adherence of M.
catarrhalis to A549 cells but that expression of the protein
is not sufficient to mediate attachment of recombinant E.
coli cells to these pneumocytes [26]. Complicating matters
is the demonstration that purified Bc5-MID, specifically
residues 713–964, binds to A549 cells [22]. These obser-
vations suggest that post-translational modification of the
protein and/or expression of a co-adhesin, neither of
which occurs in the heterologous E. coli background, is
necessary for Hag-dependent binding to A549 and Chang
monolayers. Interestingly, lack of OMPCD [48] or UspA1
[11,12] substantially decreases adherence of M. catarrhalis
to A549 and Chang cells, respectively. These molecules
may thus act in concert with Hag during attachment to
these epithelial cells. The lack of a suitable plasmid vector
for  M. catarrhalis currently precludes us from directly
addressing these issues in the native genetic background.
Only three plasmids, namely pWW102B [49], pWW115
[50] and pEMCJH04 [51], have been described for use in
M. catarrhalis. These vectors are not amenable for comple-
mention of our mutants due to the incompatibility of
antibioticR markers and replication in a restricted number
of M. catarrhalis isolates. For these reasons, we focused our
efforts on identifying region(s) of O35E-Hag important
for directly mediating adherence to HMEE and NCIH292
cells, using E. coli as a host for our experiments.
The adhesive properties of constructs 5.12, 8.18 and 10.9
imply that residues 71–384 and 746–1707 of O35E-Hag
do not specify binding to either HMEE or NCIH292 mon-
olayers (Fig. 3). These results are particularly interesting in
light of previous reports that the β-roll repeats of YadA
specify binding to both collagen and human epithelial
cells [31-35]. A recent study also indicates that the β-roll
repeats found in the N-terminus of the Actinobacillus actin-
omycetemcomicans  Oca autotransporter adhesin EmaA
specify adhesive properties [52]. The ability of construct
8.18 to confer on E. coli the ability to attach to NCIH292
cells, HMEE cells and collagen, however, demonstrates
that the β-roll structures of O35E-Hag are not required for
adherence. Although all mutated Hag proteins conferring
attachment to epithelial cells also have aa 1–70 and
1708–1964 in common (Fig. 3), it is unlikely that these
residues are directly mediating adherence. This belief is
based on previous sequence analysis of O35E-Hag indi-
cating that aa 1–66 correspond to a signal sequence and
that the last 100 residues (i.e. 1864–1964) specify a trans-
porter domain anchoring the protein in the OM [26]. Fur-
thermore, recombinant bacteria expressing the mutated
Hag proteins 6.22 and 10.32, both of which specify aa 1–
70 as well as 1708–1964 but lack most of residues 385–
745, do not bind to HMEE or NCIH292 cells (Fig. 3).BMC Microbiology 2007, 7:65 http://www.biomedcentral.com/1471-2180/7/65
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These observations support the hypothesis that aa 385–
745 of O35E-Hag contain a major epithelial cell binding
determinant.
Forsgren and colleagues previously reported that residues
764–913 of MID, which correspond to aa 715–863 of
O35E-Hag, encompass the part of the protein mediating
adherence to A549 cells and erythrocytes [22]. Our results
demonstrate that the mutated Hag construct 10.9, lacking
most of this region (see Fig. 3), binds to NCIH292 and
middle ear cells (columns N and H in Fig. 3). In addition,
E. coli carrying the plasmid pBBHS10.32, which specifies
the entire A549 binding domain (Fig. 3), does not attach
to NCIH292 or HMEE cells (columns N and H in Fig. 3).
These results suggest that the portion of Hag important for
adherence to middle ear and NCIH292 cells is different
from that specifying attachment to A549 pneumocytes.
Whether the mutated Hag constructs 10.32 or 10.9 medi-
ate adherence to A549 cells was not tested since we previ-
ously demonstrated that Hag expression is not sufficient
to confer recombinant bacteria with the ability to attach to
this particular cell line. Interestingly, the serum of COPD
patients recovering from M. catarrhalis infections contain
elevated antibody titers against MID residues 367–774
[46], which correspond to aa 355–714 of O35E-Hag.
These observations support the hypothesis that the
NCIH292 and HMEE epithelial cell binding region of Hag
has immunogenic potential, which is a desirable charac-
teristic of a vaccine candidate.
M. catarrhalis binds to extracellular matrix proteins
including fibronectin [27], vitronectin [28], and laminin
[18]; to our knowledge, the organism has not previously
been reported to bind to collagen. Our data demonstrate
that E. coli expressing the hag gene product of three M.
catarrhalis  WT isolates (i.e. O35E, V1171, and O12E)
gained the ability to attach to type IV collagen (Fig. 2C).
M. catarrhalis isolates expressing Hag, however, were
found to bind poorly to collagen (data not shown), at
least when grown under the conditions we used. One pos-
sible explanation for these conflicting results is that M.
catarrhalis  cells express an additional surface molecule
(not present in the E. coli background) that precludes Hag-
mediated binding to collagen. This hypothesis is sup-
ported by reports demonstrating that expression of certain
surface structures can adversely affect the biological func-
tion of others. For instance, Pearson and colleagues
recently showed that Hag interferes with UspA1-depend-
ent biofilm development [15]. Similarly, the expression of
type 1 fimbriae prevents Ag43-mediated autoaggregation
of E. coli cells, even though Ag43 is still expressed at WT
levels on the bacterial surface [53]. Other E. coli examples
include capsular polysaccharides blocking the function of
Ag43 [54], and the autoaggregation proteins TibA as well
as AIDA-I functioning as surface antagonists of flagellar
motility [55]. Whether M. catarrhalis expresses a molecule
inhibiting Hag-dependent adherence to collagen remains
to be determined. Another possible explanation for these
conflicting results is that Hag is expressed at greater levels
in E. coli compared to M. catarrhalis. The biological rele-
vance of M. catarrhalis binding to collagen is currently
unknown. The molecule is a major component of the
extracellular matrix that supports most tissues and type IV
collagen is found in the basal lamina, which is the layer
on which the epithelium sits. Hag-mediated binding to
collagen may therefore facilitate adherence of M. catarrh-
alis to damaged tissues during infection.
Conclusion
Hag expression is important for adherence to several
human epithelial cells relevant to pathogenesis by M.
catarrhalis, including middle ear, lung and conjunctival
cells. This Oca-family adhesin directly mediates binding
to type IV collagen as well as middle ear and NCIH292
lung cells, but its expression is not sufficient to confer
recombinant bacteria with the ability to attach to Chang
conjunctival monolayers. The collagen and epithelial cell
binding properties of Hag are separable and residues 385–
705 appear to specify the epithelial cell binding domain
of the protein. This portion of Hag is different from that
proposed by other investigators to be crucial for attach-
ment to A549 cells (i.e. 715–863). Furthermore, con-
served structural features shown to specify the adhesive
properties of the Oca adhesin YadA (i.e. β-roll), are not
important for adherence mediated by Hag. These observa-
tions suggest that Hag employs different mechanisms to
confer adherence to epithelial cells and collagen.
Methods
Bacterial strains, plasmids, tissue culture cell lines, and 
growth conditions
NCIH292, Chang and HMEE cells were cultured as previ-
ously described [23,26,30]. Table 1 lists the bacterial
strains and plasmids used in this study. M. catarrhalis was
grown on Todd-Hewitt agar plates as previously reported
[26]. Recombinant E. coli cells were cultured using Luria-
Bertani medium supplemented with chloramphenicol at
a concentration of 15 μg/ml (LB+Cm). E. coli EPI300 cells
were grown overnight in 5 ml of LB+Cm at 37°C with agi-
tation (200 rpm). The next morning, these cultures were
transferred to flasks containing 20 ml of fresh LB+Cm sup-
plemented with 250 μl of Epicentre's 1000 × Copy Con-
trol Induction Solution and grown at 37°C with vigorous
shaking (300 rpm) for 2 hr (for adherence assays and pro-
teinase K treatment experiments) or 5 hr (for purification
of plasmid DNA and protein preparations). To purify the
recombinant protein His.Hag.CT (see below), E. coli
TUNER cells carrying plasmid pBBCT.77 were cultured
overnight in 5 ml of LB+Cm supplemented with glucose
at a concentration of 0.2%. The next morning, these cul-BMC Microbiology 2007, 7:65 http://www.biomedcentral.com/1471-2180/7/65
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tures were transferred to 20 ml of fresh LB+Cm+0.2% glu-
cose and incubated with shaking at 37°C for 1 hr. Protein
expression was then induced by adding 25 μl of a 1 M
IPTG solution and incubating the cultures with vigorous
shaking for 5 hr at 37°C.
Recombinant DNA methodology
Plasmid DNA was purified from recombinant E. coli
EPI300 cells using Qiagen's Qiaprep Spin Miniprep Kit
with minor modifications to the manufacturer's instruc-
tions: two additional washes with the PE buffer were per-
formed and plasmid DNA was eluted from the columns
using 50 μl and 30 μl of elution buffer, consecutively.
Details of the other standard molecular biology tech-
niques used in this study can be found elsewhere
[23,26,30,56].
Construction of in-frame deletions within hag
Primer sewing was used to introduce deletions into the
hag ORF of M. catarrhalis strain O35E that is contained by
plasmid pELO35.Hag. Briefly, a 42-mer oligonucleotide
was designed such that the 5'-half specifies the region
directly upstream of the area to be removed and the 3'-half
corresponds to the DNA immediately downstream of the
desired deletion. This oligonucleotide, along with a
primer corresponding to its complement, was then used
to perform inverse PCR with the Stratagene QuickChange®
II XL Site-directed Mutagenesis Kit per the manufacturer's
recommended guidelines. This PCR reaction was
restricted with DpnI to remove the intact WT plasmid
DNA template, purified and electroporated into E. coli
EPI300 cells. These bacteria were allowed to recover for 1
hr at 37°C in 1 ml of LB medium and spread onto LB+Cm
agar plates. Chloramphenicol resistant colonies were
screened by colony PCR to identify clones containing the
intended deletion. Colonies were patched onto LB+Cm
plates and placed into PCR tubes. These tubes were micro-
waved on high-power for 2 min and PCR was performed
using Invitrogen's Taq DNA polymerase and hag-specific
primers flanking the deleted region of hag. This overall
strategy was used to generate plasmids pBBHS2.24,
pBBHS3.20, pBBHS5.12, pBBHS6.22, pBBHS8.18,
pBBHS10.9, and pBBHS10.32 (Table 1, Fig. 3). All plas-
mids were sequenced to verify that they contain only the
intended in-frame deletions. Construct 5.12 was found to
contain an aa substitution at residue 1541 (G1541 → V).
This mutation does not, however, affect our conclusions
that residues 385–705 are important for adherence to epi-
thelial cells and that aa 706–1194 are involved in colla-
gen-binding. This belief is based on the phenotypes of
constructs 8.18, 10.9 and 10.32 (see Fig. 3), which do not
contain this particular mutation or any other aa substitu-
tion.
Production of antibodies against the M. catarrhalis strain 
O35E-Hag protein
A PCR product corresponding to nt 4072–5892 of the
O35E-hag ORF was amplified from chromosomal DNA
with the Invitrogen Platinum Pfx DNA polymerase using
the oligonucleotide primers HagFQ1358AscI (5'-TTG
GCG CGC CTT CAA ATG AAT GTC AAA TCA-3', AscI site
underlined) and HagRF1964PacI (5'-CCT TAA TTA ACC
AAA GTG AAA ACC TGC ACC-3'; PacI site underlined).
The amplicon was purified with Epicentre's PCR Precipita-
tion Solution, digested with AscI and PacI, and ligated into
the cognate sites of the plasmid vector pETcoco-1 (Nova-
gen) using T4 DNA ligase (NEB). This ligation mixture
was introduced into E. coli EPI300 cells by electroporation
and chloramphenicol resistant transformants were
screened by colony PCR as described above using primers
that anneal to regions of pETcoco-1 flanking the cloned
DNA insert. This approach yielded the plasmid pBBCT.77,
which was sequenced to verify that no mutations were
introduced during PCR as well as to confirm that it speci-
fies a protein corresponding to aa residues 1358–1964 of
O35E-Hag fused to six N-terminal histidine residues
(encoded by pETcoco-1). This protein was designated
His.Hag.CT.
The plasmid pBBCT.77 was introduced into chemically
competent  E. coli TUNER cells (Novagen), and the
His.Hag.CT protein was purified from these recombinant
bacteria with the BugBuster HT Protein Extraction Reagent
and the His-Bind Resin System under the manufacturer's
recommended conditions (Novagen). For the production
of antibodies, female BALB/c mice were immunized with
purified His.Hag.CT emulsified in Freund's adjuvants
(complete and incomplete, Fisher Scientific) as reported
[29]. Recovered murine serum was demonstrated to rec-
ognize Hag in western blot experiments using whole cell
lysates of the WT strain O35E and its hag  mutant
O35E.TN2 (data not shown).
Protein preparations and western blot analysis
Recombinant E. coli EPI300 cells were suspended in 5 ml
PBS to an optical density of 300 Klett units, pelleted by
centrifugation and resuspended in 5 ml of 10 mM HEPES
buffer. Sarkosyl-insoluble outer membrane (OM) pro-
teins were isolated from these suspensions as described
[57]. These OM protein preparations were then analyzed
by western blot as reported [26], using murine serum
against His.Hag.CT. In some experiments, the Hag-spe-
cific monoclonal antibody 5D2 [13] was used in lieu of
murine sera against His.Hag.CT. The preparation of whole
cell lysates from M. catarrhalis and  E. coli has been
described elsewhere [58,59]. Equivalent loads of protein
were analyzed in all experiments.BMC Microbiology 2007, 7:65 http://www.biomedcentral.com/1471-2180/7/65
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For the treatment of intact bacteria with Proteinase K [60],
recombinant E. coli cells were suspended to an optical
density of 300 Klett units (109 CFU/ml) in 5 ml of 200
mM Tris-Acetate buffer (pH 8.2) supplemented with 20
mM MgSO4. Proteinase K (Novagen) was added to 0.5 ml
of bacterial suspensions at a final concentration of 0.5–
1.2 μg/ml, and these mixtures were incubated on ice for
15 min. Bacteria were next pelleted and resuspended in
~100  μl PBS supplemented with EDTA-free Protease
Inhibitor Cocktail (Roche Applied Science) at a final con-
centration of 2 ×. SDS-PAGE sample loading buffer was
then added to each suspension and they were analyzed by
western blot using Hag-reactive antibodies (see above) or
with the TonB-specific monoclonal antibody 4F1 [36].
Adherence assays
Adherence to epithelial cells was measured using a viable
cell count attachment assay previously described by our
laboratory [23,26,30,48]. For assays involving M. catarrh-
alis, bacteria were incubated with epithelial cells for 5 min
prior to washing off unbound bacteria. For assays with E.
coli, infected monolayers were incubated for 1 hr before
removing non-adherent recombinant bacteria. Duplicate
attachment assays were performed on at least 3 separate
occasions and the results are expressed as the mean (±
standard error) percentage of inoculated bacteria that
adhered to epithelial cells. Binding of E. coli strains to col-
lagen was measured using a modification of this attach-
ment assay. Recombinant E. coli cells were suspended in 5
ml of PBS supplemented with 0.15% gelatin (PBSG) to an
optical density of 230 Klett units, and 25 μl of each sus-
pension (~107 CFU) were added to duplicate wells of a 24-
well BioCoat murine type-IV collagen tissue culture plate
(BD Biosciences) containing 0.5 ml tissue culture
medium without antibiotics. Dilutions of each bacterial
suspension were spread onto LB agar plates and grown
overnight to enumerate the number of CFU used to infect
these collagen-coated wells. The inoculated tissue culture
plate was centrifuged at 165 × g for 5 min and placed in a
37°C incubator with 7.5% CO2 for 1 hr. Each infected
well was then washed five times with 0.5 ml PBSG, fixed
with 0.5 ml methanol and stained for 15 min with 0.5 ml
of a solution containing 0.035% crystal violet and 5%
methanol. Wells were washed three times with deionized
H2O, dried, and photographed on either side of a point in
the center of the well (2 fields/well). The number of bac-
terial cells per field was counted by two individuals and
each strain was tested on at least 2 separate occasions. The
results are expressed as the mean number of bacterial cells
(± standard error) per field normalized by the number of
CFU used to inoculate the collagen-coated wells.
Sequence and statistical analyses
Plasmids were sequenced at the University of Michigan
sequencing core. The resulting chromatograms were
assembled using the ChromaTool software (BioTools,
Inc.), and sequence analysis was performed using Vector
NTI 10.1.1 (Invitrogen). Statistical analyses were per-
formed using the Mann-Whitney test provided by the
GraphPad Prism Software v. 4.0 (GraphPad). P values less
than 0.05 were considered statistically significant.
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